IRIS-PHARMA
Keen Eye , a French technology company specialized in image analysis for the life science industry, announced today a strategic partnership agreement with Iris Pharma , a world-wide leading ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug / device development services. The partnership aims at providing Iris Pharma artificial intelligence (AI) applications to make assays faster, more reliable and more efficient.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181009005491/en/
For Sylvain Berlemont, Founder & CEO of Keen Eye, “We are very happy to team up and bring our expertise in computer vision to Iris Pharma. Through this partnership, we are expecting to contribute to the most challenging image-based assays to better fight eye diseases”.
For Yann Quentric, President of Iris Pharma, « The advanced AI technology of Keen Eye allows us to optimize the performance of the bioimaging analysis during the preclinical ophthalmic drug development, and in the future for clinical development. Their solution is faster than classical methods, robust and reliable, erasing inter-individual variability, improving Iris Pharma and its customers ability to develop ocular innovative products. »
About Keen Eye
Seeing Beyond Pixels
Founded in 2013, Keen Eye is a technology company based in Paris; aiming
at bringing AI into every laboratory for the benefit of biologists,
pathologists and patients. The company is building decision-support and
GLP-compliant image analysis solutions to accelerate the development of
new therapies with better, faster and accurate analytics.
Keen Eye
develops web-based solutions which help biologists and pathologists that
usually spend thousands of hours on the microscope. Among others, Keen
Eye delivers image quantification applications using its deep learning
technology.
For more information: www.keeneye.tech
About Iris Pharma
A leading CRO dedicated to ophthalmology, Iris Pharma helps clients around the world navigate every stage of the drug and device development process – including in vivo screening, proof of concept, ocular efficacy, GLP preclinical studies, bioanalysis, clinical trials, and marketing surveys. This CRO has expertise in all ophthalmic indications, and supports clients ranging from small start-ups to large pharmaceutical companies in moving forward products that directly or indirectly affect eye health.
For more information: www.iris-pharma.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20181009005491/en/
Contact:
Press Iris Pharma Yann Quentric marketing@iris-pharma.com or Keen Eye Sylvain Berlemont contact@keeneye.tech
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Graanul - Expiry of Consent Solicitation and Scheme Solicitation22.8.2025 17:04:00 CEST | Press release
Graanul: Expiry of Consent Solicitation and Scheme Solicitation for Graanul’s: €250,000,000 Floating Rate Sustainability-Linked Senior Secured Notes due 2026 (Regulation S Notes: ISIN Number XS2397354015 / Common Code 239735401 Rule 144A Notes: ISIN Number XS2397354288 / Common Code 239735428) (the “Existing Floating Rate Notes”) and €380,000,000 4.625% Sustainability-Linked Senior Secured Notes due 2026 (Regulation S Notes: ISIN Number XS2397354528 / Common Code 239735452 Rule 144A Notes: ISIN Number: XS2397355095 / Common Code 239735509) (the “Existing Fixed Rate Notes” and, together with the Existing Floating Rate Notes, the “Existing Notes”) of Cullinan Holdco SCSp a special limited partnership (société en commandite spéciale) established under the laws of Luxembourg, having its registered office at 2, avenue Charles de Gaulle, L-1653, registered with the Luxembourg Register of Commerce and Companies under number B-256979 (the “Issuer” and together with its subsidiaries, “Graanul”)
ATP and PIF announce ATP Tennis IQ Powered by PIF, unlocking access to performance analytics to all singles players across the PIF ATP Rankings for the first time ever22.8.2025 17:04:00 CEST | Press release
ATP Tennis IQ Powered by PIF is a next-generation technology platform, delivering advanced scouting, video analysis and innovative wearable insights The enhanced platform will be accessible to all singles players across the PIF ATP Rankings The launch is one of the most significant technological advances in the sport, significantly expanding access to world-class data and performance analytics The ATP and PIF today announced the launch of ATP Tennis IQ Powered by PIF, a next-generation technology platform revolutionizing the future of tennis by enabling enhanced access to data, insights and advanced match analytics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250821261766/en/ The platform will unlock opportunities and expand access to more players, empowering up to 2,000 players across the ATP Tour and ATP Challenger Tour, the launchpad to men’s professional tennis, to reach their full performance potential and level the
Rimini Street and American Digital Partner to Deliver Alternative SAP, Oracle and VMware Support, Savings and Innovation on HPE Infrastructure22.8.2025 15:00:00 CEST | Press release
Clients can avoid low ROI software upgrades and migrations, achieve a reduction in total IT support costs by up to 90% and leverage full potential of existing systems without re-platforming Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced its strategic partnership with American Digital, a leading IT solutions provider specializing in custom data center solutions based on HPE infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250822554104/en/ Rimini Street and American Digital Partner to Deliver Alternative SAP, Oracle and VMware Support, Savings and Innovation on HPE Infrastructure The strategic alliance provides North America based clients with a full-stack solution, with Rimini Street providing comprehensive software support and ma
The New Belkin UltraCharge Collection Brings Fast, Stylish Power at 25W22.8.2025 15:00:00 CEST | Press release
The world’s first Qi2 25W certified lineup offers faster and smarter wireless charging experiences, designed for next-gen devices Belkin, a leading consumer electronics brand for over 40 years, today announced three new Qi2 25W certified wireless charging solutions, expanding its award-winning mobile power portfolio. These new products harness the power of the latest Qi2 standard, delivering up to 25W wireless charging with enhanced efficiency, thermal management, and cross-device compatibility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250822916646/en/ Belkin UltraCharge 25W Collection The announcement follows Belkin’s successful certification of multiple products under the new Qi2 25W protocol, setting the stage for high-performance, future-ready accessories that meet the evolving needs of consumers and devices alike. All three UltraCharge products are thoughtfully engineered with Belkin’s hallmark focus on safety, pe
Tacton Appoints Klaus Andersen as CEO to Lead Next Phase of Global Growth22.8.2025 15:00:00 CEST | Press release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and leading SaaS platform simplifying sales and configuration processes for manufacturers of complex products, today announced that Klaus Andersen,currently serving as Chief Operating Officer, has been appointed Chief Executive Officer, effective August 21, 2025. He succeedsBo Gyldenvang,who is stepping down after leading the company through a pivotal and successful period of transformation and growth. Bo will remain an advisor to the company’s board of directors and executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250822177255/en/ Tacton CEO Klaus Andersen Klaus brings with him more than two decades of executive leadership experience, with a distinguished track record of leadership and value creation. Prior to joining Tacton, Klaus served as CEO of several high-growth global technology companies, successfully leading multiple exits an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom